PT  - JOURNAL ARTICLE
AU  - Amrita Rao
AU  - Huiting Ma
AU  - Gary Moloney
AU  - Jeffrey C Kwong
AU  - Peter Jüni
AU  - Beate Sander
AU  - Rafal Kustra
AU  - Stefan D Baral
AU  - Sharmistha Mishra
TI  - A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada
AID  - 10.1101/2021.02.15.21251572
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.15.21251572
4099  - http://medrxiv.org/content/early/2021/03/11/2021.02.15.21251572.short
4100  - http://medrxiv.org/content/early/2021/03/11/2021.02.15.21251572.full
AB  - Shelter-in-place mandates and closure of non-essential businesses have been central to COVID-19 response strategies including in Toronto, Canada. Approximately half of the working population in Canada are employed in occupations that do not allow for remote work suggesting potentially limited impact of some of the strategies proposed to mitigate COVID-19 acquisition and onward transmission risks and associated morbidity and mortality. We compared per-capita rates of COVID-19 cases and deaths from January 23, 2020 to January 24, 2021, across neighborhoods in Toronto by proportion of the population working in essential services. We used person-level data on laboratory-confirmed COVID-19 community cases (N=74,477) and deaths (N=2319), and census data for neighborhood-level attributes. Cumulative per-capita rates of COVID-19 cases and deaths were 3-fold and 2.5-fold higher, respectively, in neighborhoods with the highest versus lowest concentration of essential workers. Findings suggest that the population who continued to serve the essential needs of society throughout COVID-19 shouldered a disproportionate burden of transmission and deaths. Taken together, results signal the need for active intervention strategies to complement restrictive measures to optimize both the equity and effectiveness of COVID-19 responses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Canadian Institutes of Health Research (grant no. VR5-172683).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Toronto Health Sciences Research Ethics Board (protocol no. 39253) approved the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this study can be made available upon request.CCM+Case and Contact Management SolutionsDAdissemination areasIQRinterquartile range